Quantum Biopharma (QNTM) Assets (2018 - 2026)
Quantum Biopharma (QNTM) posted Assets of $14.9 million for Q1 2026, up 33.74% sequentially from $11.2 million in Q4 2025, and little changed YoY from $14.9 million in Q1 2025.
Quantum Biopharma (QNTM) Assets (2018 - 2026) Analysis & Trends
Quantum Biopharma has reported Assets for 9 years, with the latest figure at $14.9 million in Q1 2026.
- Quarterly Assets changed 0.35% year-over-year to $14.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.9 million (changed 0.35% YoY) and the FY2025 annual result came in at $11.2 million, down 34.8% from the prior year.
- Assets grew to $14.9 million in Q1 2026 per QNTM's latest filing, from $11.2 million in the prior quarter.
- Over five years, Assets peaked at $38.4 million in Q4 2022 and troughed at $11.2 million in Q4 2025.
- A 5-year average of $17.8 million and a median of $15.3 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2023 and 2026: Assets slumped 54.51% in 2023, then increased 0.35% in 2026.
- Over 5 years, Assets stood at $38.4 million in 2022, then plunged by 54.51% to $17.5 million in 2023, then declined by 2.03% to $17.1 million in 2024, then slumped by 34.8% to $11.2 million in 2025, then soared by 33.74% to $14.9 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $14.9 million, $11.2 million, and $14.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.14 Bn | 132.29 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.03 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.12 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 60.84 Bn | 55.70 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.15 Bn | 37.06 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.49 Bn | 28.18 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.78 Bn | 10.38 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.14 Bn | 26.31 Bn | - | 19.82 Bn |
| 10 | Quantum Biopharma | 15.62 Mn | 11.98 Mn | - | 14.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.39 Mn |
| Mar 31, 2026 | 14.93 Mn |
| Dec 31, 2025 | 11.16 Mn |
| Sep 30, 2025 | 14.15 Mn |
| Jun 30, 2025 | 15.30 Mn |
| Mar 31, 2025 | 14.87 Mn |
| Dec 31, 2024 | 17.12 Mn |
| Sep 30, 2024 | 19.03 Mn |
| Jun 30, 2024 | 15.25 Mn |
| Dec 31, 2023 | 17.47 Mn |
| Dec 31, 2022 | 38.41 Mn |
| Dec 31, 2021 | 62.96 Mn |
| Dec 31, 2020 | 41.97 Mn |
| Dec 31, 2019 | 43.52 Mn |
| Dec 31, 2018 | 39.98 Mn |